Orgenesis Inc. (NASDAQ:ORGS – Get Free Report)’s share price was down 13.1% during mid-day trading on Friday . The stock traded as low as $1.39 and last traded at $1.39. Approximately 3,112 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 8,511 shares. The stock had previously closed at $1.60.
Orgenesis Stock Performance
The stock’s 50-day moving average price is $1.44.
About Orgenesis
Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.
Recommended Stories
- Five stocks we like better than Orgenesis
- Stock Dividend Cuts Happen Are You Ready?
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Buy P&G Now, Before It Sets A New All-Time High
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Best Stocks Under $5.00
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
